Phosphorescent heteroleptic phenylbenzimidazole dopants and new synthetic methodology
US8795850B2 · kind B2 · utility
11Cited by
31References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2011 |
| Grant date | Aug 5, 2014 |
| Priority date | — |
| Expiry date | Dec 28, 2032 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH10K2101/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel heteroleptic iridium complexes are provided. These iridium complexes are useful compounds in OLED devices. The ligands for these novel complexes may be obtained using a new synthetic methodology that utilizes manganese dioxide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.